Ushbu ish iqtibos qilgan ishlar

70 ta ish

Ish: Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis

1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

   Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

   Maqola202155 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.080154

2. Quantifying heterogeneity in a meta‐analysis

   Julian P. T. Higgins, Simon G. Thompson

   Maqola20026 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.307853

3. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

   Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena +20

   Maqola20132 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.098698

4. Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma

   Davendra Sohal, Mai Duong, Syed A. Ahmad +9

   Maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.263852

5. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

   Eva Versteijne, Jacob L. van Dam, Mustafa Suker +30

   Maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.466634

6. Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

   John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox +22

   Maqola20122 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.485324

7. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.485322

8. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.485323

9. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.485325

10. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485326

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485327

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485328

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485329

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485330

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485331

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485332

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485333

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485334

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485335

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485336

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485337

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485338

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485339

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485340

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.485341